STIRLING Pharmaceuticals is set
to sure up its Canadian presence,
following license approval for a
manufacturing plant in Nova Scotia.
“We are pleased to finally achieve
full licensing of our pharma
manufacturing plant, which now
positions the company to pursue
contract manufacturing revenues,
as well as to commence
formulation and production of a
unique suite of Stirling Health
branded products,” said Stirling
Products md, Peter Boonen.
Plans are now underway for the
new plant to feature capability to
manufacture Stirling branded OTC,
prescription and natural therapies.The above article was sent to subscribers in Pharmacy Daily's issue from 11 Jan 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Jan 11
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.